Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy (Q66077639)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy
clinical trial

    Statements

    A Randomized Trial of Sirolimus (Rapamune) for Relapse Prevention in Patients With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy (English)
    0 references
    0 references
    19 December 2016
    0 references
    31 August 2023
    0 references
    118
    0 references
    2 year
    0 references
    99 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit